Shift Bioscience Bags $16m to Develop Novel Therapies for Age-related Diseases

Shift Bioscience Bags $16m to Develop Novel Therapies for Age-related Diseases

Shift Bioscience, a biotechnology startup using generative AI to explore how gene activation can reverse the aging process, has secured $16 million in seed funding to further develop its cell simulation AI platform. The funding round was led by BGF, with significant contributions from Kindred Capital, F-Prime Capital, and Jonathan Milner.

Please login to comment on this Post

Most Visited Posts

1

Education November 06, 2023

Value Based Questions for Class 5

Value Based Questions for Class 5 Value based questions give specific situations in the form of questions to students and students have to understand what values they will get in the situations.

2

Fashion March 08, 2025

The Stylish and Comfortable Pink Palm Puff Hoodie

The Pink Palm Puff Hoodie is crafted from...

3

Automotive October 14, 2024

Overview of the Electric Vehicle Charging Stations Market

Meticulous Research®, a prominent global...

4

Business January 20, 2026

Choosing a New Market Greek Catering Service That Actually Delivers

When people search for a New Market Greek...

5

Building and Construction February 10, 2024

Durable Sandwich Panels for Walls - Revamp Your Space - Everest Industries

Discover Everest Rapicon Readymade Walls, innovative prefabricated sandwich panels designed to optimize space utilization and streamline labor input for rapid construction projects. https://www.everestind.com/boards-and-panels/rapicon

6

Health April 01, 2024

Tablets for Hope: Addressing Ovarian Inefficiency in Women’s Reproductive Health

Enclomiphene buy is a medication that belongs to a class of drugs known as selective oestrogen receptor modulators (SERMs). It works by stimulating the release of hormones necessary for ovulation, thereby increasing the chances of conceiving.